| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |